(Q26779719)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Viruses, schizophrenia, and bipolar disorder

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

The risk for schizophrenia from childhood and adult infections

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Drug development in schizophrenia: are glutamatergic targets still worth aiming at?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Glutamate and dopamine in schizophrenia: an update for the 21st century

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Placebo response in antipsychotic clinical trials: a meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Immunology of schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Glutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Autoimmune diseases and infections as risk factors for schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Immune System and Schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

The association of infectious agents and schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Immunity and immunopathology to viruses: what decides the outcome?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Neuro-immune crosstalk in CNS diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Association between prenatal exposure to bacterial infection and risk of schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Dual role of inflammation in CNS disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Grey matter changes can improve the prediction of schizophrenia in subjects at high risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Serologic evidence of prenatal influenza in the etiology of schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Childhood meningitis, brain maturation and the risk of psychosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Cytokines, stress and depressive illness: brain‐immune interactions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Maternal infections and subsequent psychosis among offspring.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Cytokine-induced sickness behavior: where do we stand?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

The psychiatric symptoms of rheumatic fever.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Neuropharmacology of quinolinic and kynurenic acids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

The current status of the dopamine hypothesis of schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Diagnosis and pathogenesis of CNS lupus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Vulnerability--a new view of schizophrenia

28 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

28 September 2017

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

7 January 2021

inferred from DOI database lookup

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Neuroinflammation in schizophrenia-related psychosis: a PET study.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Schizophreniform disorder with cerebrospinal fluid PCR positivity for herpes simplex virus type 1.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Increased cortical kynurenate content in schizophrenia

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Administration of interleukin-1 at birth affects dopaminergic neurons in adult mice.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Cerebral involvement of scleroderma presenting as schizophrenia-like psychosis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease-associated polypeptides as fibrin fragments

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Depression as a cerebral manifestation of scleroderma: immunological findings in serum and cerebrospinal fluid

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

31 May 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Interleukin-1, but not stress, stimulates glucocorticoid output during early postnatal life in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Age and neuroinflammation: a lifetime of psychoneuroimmune consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Stress, schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Imbalanced kynurenine pathway in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Chain reaction or time bomb: a neuropsychiatric-developmental/neurodevelopmental formulation of tourettisms, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Antibodies to infectious agents in individuals with recent onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Clinical effects of COX-2 inhibitors on cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Psychosis following acute Sydenham's chorea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Exposure to Prenatal and Childhood Infections and the Risk of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Association of an Interleukin-1β Genetic Polymorphism With Altered Brain Structure in Patients With Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNINS.2015.00372

Maternal infection during pregnancy and schizophrenia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

Herpes simplex type 2 virus encephalitis presenting as psychosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612505

[An adult case suspected of recurrent measles encephalitis with psychiatric symptoms]

28 November 2018

1 reference

12 December 2020

Immunology. How frustration leads to inflammation

1 reference

12 December 2020

Nonaffective psychosis after prenatal exposure to rubella

1 reference

12 December 2020

Possible anti-catatonic effects of minocycline in patients with schizophrenia

1 reference

12 December 2020

Adjunctive recombinant human interferon gamma-1b for treatment-resistant schizophrenia in 2 patients

1 reference

12 December 2020

Psychiatric disorders in the encephalitic form of multiple sclerosis

1 reference

12 December 2020

Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity

1 reference

12 December 2020

Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis

1 reference

12 December 2020

Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond

1 reference

12 December 2020

[Therapy-resistant depression with fatigue. A case of presumed streptococcal-associated autoimmune disorder]

1 reference

12 December 2020

Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes

1 reference

12 December 2020

The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes

1 reference

12 December 2020

Identifiers

DOI

10.3389/FNINS.2015.00372

1 reference

1259792

1259792

1 reference

1 reference

1 reference